High throughput CRISPR screening identifies genes involved in macrophage viability and inflammatory pathways

Abstract Macrophages are critical cells of the innate immune system involved in the recognition and destruction of invading microbes in addition to the resolution of inflammation and maintenance of homeostasis. Understanding the genes involved in all aspects of macrophage biology is essential to gaining new insights into immune system dysregulation during diseases that range from autoinflammatory to cancer. Here we utilize high throughput clustered regularly interspaced short palindromic repeats (CRISPR) screening to generate a resource that identifies genes required for macrophage viability and function. First, we employ a pooled based CRISPR/Cas nuclease active screening approach to identify essential genes required for macrophage viability by targeting genes within coding exons. In addition, we also target 3’UTRs to gain insights into new cis-regulatory regions that control expression of these essential genes. Second, using our recently generated NF-κB reporter macrophage line, we perform a fluorescence-activated cell sorting (FACS)-based high-throughput genetic screen to identify regulators of inflammation. We identify a number of novel positive and negative regulators of the NF-κB pathway as well as unraveling complexities of the TNF signaling cascade showing it can function in an autocrine manner to negatively regulate the pathway. Utilizing a single complex library design we are capable of interrogating various aspects of macrophage biology, generating a resource for future studies. Author Summary Excess inflammation is associated with a variety of autoimmune diseases and cancers. Macrophages are important mediators of this inflammatory response. Defining the genes involved in their viability and effector function is needed to completely understand these two important aspects of macrophage biology. Here we screened over 21,000 genes and generated a resource guide of genes required for macrophage viability as well as novel positive and negative regulators of NF-κB signaling.

[1]  John G Doench,et al.  High-Throughput CRISPR Screens To Dissect Macrophage-Shigella Interactions , 2020, bioRxiv.

[2]  Aviv Regev,et al.  MAUDE: inferring expression changes in sorting-based CRISPR screens , 2019, Genome Biology.

[3]  Erin E. Gill,et al.  A Genome-Wide Knockout Screen in Human Macrophages Identified Host Factors Modulating Salmonella Infection , 2019, mBio.

[4]  C. Mayr.  What Are 3' UTRs Doing? , 2018, Cold Spring Harbor perspectives in biology.

[5]  Jennifer A. Doudna,et al.  CRISPR-Cas guides the future of genetic engineering , 2018, Science.

[6]  S. Zheng,et al.  Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications , 2018, Front. Immunol..

[7]  Jorge Andrade,et al.  Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication , 2018, Cell reports.

[8]  N. Perrimon,et al.  Pooled genome-wide CRISPR screening for basal and context-specific fitness gene essentiality in Drosophila cells , 2018, bioRxiv.

[9]  S. Orkin,et al.  Mapping the Mouse Cell Atlas by Microwell-Seq , 2018, Cell.

[10]  Michael T. McManus,et al.  Dual gene activation and knockout screen reveals directional dependencies in genetic networks , 2018, Nature Biotechnology.

[11]  C. Mayr.  Regulation by 3'-Untranslated Regions. , 2017, Annual review of genetics.

[12]  Michael T. McManus,et al.  Tracing cellular heterogeneity in pooled genetic screens via multi-level barcoding , 2017, BMC Genomics.

[13]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[14]  Michael T. McManus,et al.  CRISPR/Cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-κB reporter , 2017, The Journal of Biological Chemistry.

[15]  A. Gasbarrini,et al.  Can We Predict the Efficacy of Anti-TNF-α Agents? , 2017, International journal of molecular sciences.

[16]  N. Ahituv,et al.  CRISPR–Cas9-mediated functional dissection of 3′-UTRs , 2017, Nucleic acids research.

[17]  Shao-Cong Sun,et al.  NF-κB signaling in inflammation , 2017, Signal Transduction and Targeted Therapy.

[18]  Wenqian Hu,et al.  Translation repression via modulation of the cytoplasmic poly(A)-binding protein in the inflammatory response , 2017, eLife.

[19]  Eric S. Lander,et al.  Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.

[20]  Nir Hacohen,et al.  A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors , 2016, Nature Genetics.

[21]  Julio Saez-Rodriguez,et al.  A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia , 2016, Cell reports.

[22]  A. E. Erson-Bensan.  Alternative polyadenylation and RNA-binding proteins. , 2016, Journal of molecular endocrinology.

[23]  Douglas A. Chapnick,et al.  Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration , 2016, Nucleic acids research.

[24]  P. Gros,et al.  The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation , 2016, The Journal of experimental medicine.

[25]  T. Golub,et al.  High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines , 2016, Nature Biotechnology.

[26]  D. Durocher,et al.  High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.

[27]  Dhruv Chauhan,et al.  A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation* , 2015, The Journal of Biological Chemistry.

[28]  Jun S. Liu,et al.  MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.

[29]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[30]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[31]  Taro Kawai,et al.  Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..

[32]  S. Ghosh,et al.  Regulation of the NF-κB-Mediated Transcription of Inflammatory Genes , 2014, Front. Immunol..

[33]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[34]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[35]  Traver Hart,et al.  Finding the active genes in deep RNA-seq gene expression studies , 2013, BMC Genomics.

[36]  P. Massion,et al.  Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells. , 2013, Cancer research.

[37]  Martin Kampmann,et al.  Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells , 2013, Proceedings of the National Academy of Sciences.

[38]  C. Glass,et al.  Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription , 2013, Nature.

[39]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[40]  Thomas A. Wynn,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[41]  Xixi Ma,et al.  TNF inhibitor therapy for rheumatoid arthritis (Review) , 2013 .

[42]  S. Smale.  Transcriptional regulation in the innate immune system. , 2012, Current opinion in immunology.

[43]  L. Peyrin-Biroulet,et al.  Anti-TNF therapy in inflammatory bowel diseases: a huge review. , 2010, Minerva gastroenterologica e dietologica.

[44]  T. Lawrence.  The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[45]  Ruslan Medzhitov,et al.  Transcriptional control of the inflammatory response , 2009, Nature Reviews Immunology.

[46]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[47]  D. Symmons,et al.  Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity , 2009, Rheumatology.

[48]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[49]  P. Blackshear,et al.  Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity , 2006, European journal of immunology.

[50]  Yimin,et al.  A Regulatory Effect of the Balance between TNF-α and IL-6 in the Granulomatous and Inflammatory Response to Rhodococcus aurantiacus Infection in Mice1 , 2006, The Journal of Immunology.

[51]  C. Ware,et al.  TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. , 1998, Journal of immunology.

[52]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.

[53]  C. Kleiveland,et al.  Peripheral Blood Mononuclear Cells , 2015 .

[54]  Xixi Ma,et al.  TNF inhibitor therapy for rheumatoid arthritis. , 2013, Biomedical reports.